[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100485558":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":28,"centralContacts":29,"locations":35,"responsibleParty":52,"collaborators":28,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":28,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":28,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":78,"overallStatus":38,"whyStopped":28,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Al-Azhar University","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"interscalene analgesia (Group ISBPB)","ACTIVE_COMPARATOR","All patients will receive a supraclavicular block as their primary anesthetic. Brachial plexus blocks will be performed at the supraclavicular fossa using 20 to 30 mL of 0.5% bupivacaine under ultrasound guidance.\n\nThe C5 to C7 or C5 to C8 nerve roots between the anterior scalene and middle scalene muscles will be visualized in the absence of the subclavian artery and 10 mL 0.125% bupivacaine will be injected around the nerve roots of the brachial plexus. The needle trajectory will be adjusted to facilitate the even distribution of the local anesthetic around each nerve root.",[13],"Drug: bupivacaine, midazolam",{"label":15,"type":10,"description":16,"interventionNames":17},"The intercostobrachial nerve block ( Group ICBN)","All patients will receive a supraclavicular block as their primary anesthetic. Brachial plexus blocks will be performed at the supraclavicular fossa using 20 to 30 mL of 0.5% bupivacaine under ultrasound guidance.\n\nThe ICBN block will be performed with 10 mL of 0.5% bupivacaine in the plane deep to the pectoralis minor and\u002For serratus anterior muscle over the second and third intercostal space.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Patient-Controlled Analgesia (Group PCA)","All patients will receive a supraclavicular block as their primary anesthetic. Brachial plexus blocks will be performed at the supraclavicular fossa using 20 to 30 mL of 0.5% bupivacaine under ultrasound guidance.",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"DRUG","bupivacaine, midazolam","Patients will be provided with midazolam (up to 2 mg) if requested. No opioids will be administered before the incision. At the first patient complaint of pain, the intraoperative anesthesia team will document the quality and location of pain, and 50 microgram of fentanyl will be administered if the patient requested it or pain score more than 3",[19,15,9],null,[30],{"name":31,"role":32,"phone":33,"phoneExt":28,"email":34},"Neveen A. Kohaf, Ph.D","CONTACT","+201069482380","nevenabdo@azhar.edu.eg",[36],{"facility":37,"status":38,"city":39,"state":28,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Facualty of Medicine(Damietta), Al Azhar University","RECRUITING","Damietta","34711","Egypt","EG",{"type":44,"coordinates":45},"Point",[46,47],31.81332,31.41648,{"lat":47,"lon":46},[50],{"name":31,"role":32,"phone":51,"phoneExt":28,"email":34},"01069482380",{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":28,"oldOrganization":28},"PRINCIPAL_INVESTIGATOR","Neveen Abd El Maksoad Kohaf","Lecturer of Clinical Pharmacy","100485558","phase-4-analgesic-effect-of-supraclavicular-block-and-interscalene-analgesia-versus-an-intercostobrachial-nerve-block-versus-pca-in-forearm-surgery-100485558",false,"NCT05602636","Analgesic Effect of Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA in Forearm Surgery","Efficacy of Combined US-Guided Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA With Fentanyl on Preventing Tourniquet Pain in Forearm Surgery: A Randomized Clinical Trial","Inclusion Criteria:\n\n* aged more than 18 years,\n* ASAI-III patients\n* scheduled to undergo orthopedic or plastic surgery distal to the elbow with an anticipated tourniquet duration greater than 45 min.\n* desiring regional anesthesia as the primary anesthetic.\n\nExclusion Criteria:\n\n* Contraindication to regional anesthesia.\n* Allergy to local anesthetics.\n* Primary block failure.\n* If patients desired deep intraoperative sedation.\n* Clinically significant cognitive impairment.","ALL","18 Years","70 Years",{"count":67,"type":68},60,"ESTIMATED","INTERVENTIONAL",[71],"PHASE4","The etiology of tourniquet pain is complex, and the study team hypothesizes that blocking with Interscalene brachial plexus block (ISBPB) is more efficient in decreasing the incidence of tourniquet pain in comparison with other techniques.\n\nAs there is a paucity of studies that evaluate the effect of intercostobrachial nerve (ICBN) block and ISBPB and Patient-Controlled Analgesia (PCA) with a supraclavicular brachial plexus block (SCBPB) on tourniquet pain in forearm surgery, Therefore, we established this randomized study to compare ISBPB and ICBN and PCA with fentanyl with SCBPB in terms of the incidence and severity of tourniquet pain in patients undergoing forearm surgery.",[74,75,76,77],"Forearm Surgery","US-Guided Supraclavicular Block","Interscalene Analgesia","Tourniquet Pain",[79,80],"Intercostobrachial Nerve Block","PCA with Fentanyl","2026-01-04",{"date":83,"type":84},"2026-01-06","ACTUAL",{"date":86,"type":84},"2022-12-10",{"date":88,"type":68},"2025-12-30",{"name":5,"class":6},1]